Demographic disparities influencing survival of patients with glioblastoma.

被引：0
|
作者：
Ayoobkhan, Fathima Shehnaz
Ganiyani, Mohammad Arfat
Pustake, Manas
Ahmad, Shahzaib
Podder, Vivek
Bellur, Shreyas S.
Howal, Prashant
Shah, Aditya
Goodman, Judie R.
机构：
[1] Wayne State Univ, Trinity Hlth Oakland Hosp, Pontiac, MI USA
[2] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[3] Grant Govt Med Coll, Mumbai, Maharashtra, India
[4] Grant Med Coll, Mumbai, Maharashtra, India
[5] Wayne State Univ, Sch Med, Trinity Hlth Oakland Hosp, Pontiac, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13795
引用
收藏
页数：1
相关论文
共 50 条
  • [41] DECISION TREE FOR THE ONCOLOGY NURSE CARING FOR PATIENTS WITH GLIOBLASTOMA.
    Schwartz, Margaret
    Lezon, Raymond
    Maher, Mary Ellen
    Mora, Kellie
    Onuselogu, Lynnette
    Rizio, Nicole
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 97 - 98
  • [42] Nursing Care for Glioblastoma.
    Schehlmann, R. C.
    ONKOLOGIE, 2010, 33 : 56 - 56
  • [43] Clinical and Demographic Factors Influencing Survival in Patients with Inflammatory Breast Cancer
    Mahendraraj, K.
    Di Como, J. A.
    Chamberlain, R. S.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S74 - S75
  • [44] The Impact of Intraoperative MRI and Other Factors on Survival for Patients With Newly Diagnosed Glioblastoma. A Multicenter Assessment of Over 800 Patients
    Shah, Amar S.
    Sylvester, Peter
    Vellimana, Ananth K.
    Dunn, Gavin P.
    Evans, John
    Jensen, Randy L.
    Honeycutt, John H.
    Sutherland, Garnette R.
    Cahill, Daniel P.
    Shah, Mitesh V.
    Abram, Steven R.
    Oswood, Mark C.
    Kim, Albert H.
    Leuthardt, Eric C.
    Dowling, Joshua L.
    Rich, Keith M.
    Dacey, Ralph G.
    Zipfel, Gregory J.
    Tao, Yu
    Chicoine, Michael R.
    NEUROSURGERY, 2018, 65 : 120 - 121
  • [45] Demographic Disparities in Patterns of Care and Survival Outcomes for Patients with Resected Gastric Adenocarcinoma
    Stessin, Alexander M.
    Sherr, David L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (02) : 223 - 233
  • [46] Hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma.
    Lewitzki, V.
    Sweeney, R.
    Klement, R. J.
    Grosu, A.
    Polat, B.
    Popp, I.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S103 - S103
  • [47] The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
    Press, Robert H.
    Shafer, Sarah L.
    Jiang, Renjian
    Buchwald, Zachary S.
    Abugideiri, Mustafa
    Tian, Sibo
    Morgan, Tiffany
    Behera, Madhusmita
    Sengupta, Soma
    Voloschin, Alfredo Daniel
    Olson, Jeffrey J.
    Curran, Walter John, Jr.
    Eaton, Bree Ruppert
    Shu, Hui-Kuo George
    Zhong, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Phase I safety and bioimaging trial of ifabotuzumab in patients with glioblastoma.
    Gan, Hui K.
    Cher, Lawrence
    Inglis, Po
    Lwin, Zarnie
    Lau, Eddie
    Wichmann, Christian
    McDonald, Alex
    Gunjur, Ashray
    Ackermann, Uwe
    Remen, Kirsten
    Fluck, Kate
    Bolarnos, Gel
    Guo, Nancy
    Lee, Sze Ting
    Gong, Sylvia
    Palmer, Jodie B.
    Pathmaraj, Kunthi
    O'Keefe, Graeme J.
    Scott, Fiona E.
    Day, Bryan W.
    Boyd, Andrew W.
    Thomas, Paul
    Ahmed, Omar
    Chappell, Dale
    Durrant, Cameron
    Scott, Andrew M.
    CANCER RESEARCH, 2021, 81 (13)
  • [49] Efficacy and safety study of fotemustine and bevacizumab in patients with recurrent glioblastoma.
    Escudero, Laura Sanchez
    Urbano, Maria Amor
    Garces, Maria Yeray Rodriguez
    Murillo, Fatima Toscano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] The impact of the time to start radiotherapy (TRT) on overall survival in newly diagnosed glioblastoma.
    Santos, Vanessa Montes
    Mesquita, Marcella Coelho
    Estevez-Diz, Maria Del Pilar
    Marta, Gustavo N.
    Feher, Olavo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345